Social Security Disability for Multiple Myeloma: Blue Book 13.07 and How to Qualify in 2026

Multiple myeloma is a blood cancer that starts in the plasma cells of your bone marrow. It is not curable in most cases, and the treatments are brutal. Chemo, targeted drugs, stem cell transplants, radiation. Even when treatment works, the side effects can wreck your ability to hold down a job for months or years at a time.

About 36,000 people get diagnosed with multiple myeloma every year in the United States, and roughly 192,000 Americans are currently living with it. The five-year survival rate has improved to about 62%, which is good news, but that improvement comes with aggressive treatment that often leaves people unable to work.

If that is your situation, Social Security disability benefits may be able to help. Multiple myeloma has its own listing in the SSA Blue Book under Section 13.07, and there are multiple ways to qualify. Let me break down exactly how this works.

What Is Multiple Myeloma and Why Does It Affect Your Ability to Work?

Multiple myeloma is a cancer of the plasma cells. These are white blood cells that normally make antibodies to fight infections. When they turn cancerous, they crowd out healthy blood cells in the bone marrow and produce abnormal proteins that can damage your kidneys, bones, and immune system.

The symptoms that make working difficult include:

• Bone pain and fractures - Myeloma weakens bones from the inside. About 80% of patients have bone disease at diagnosis. Vertebral compression fractures, rib fractures, and long bone lesions can make sitting, standing, and lifting extremely painful.
• Severe fatigue - This is not regular tiredness. Anemia from myeloma combined with treatment side effects creates a level of exhaustion that makes even simple tasks feel impossible.
• Frequent infections - Myeloma suppresses your immune system. You catch everything. Pneumonia, urinary tract infections, skin infections. Each one can put you in bed for days or weeks.
• Kidney damage - Abnormal proteins from myeloma cells can clog up your kidneys. About 20-40% of myeloma patients develop some level of kidney impairment.
• Peripheral neuropathy - Several myeloma drugs, especially bortezomib and thalidomide, cause nerve damage in the hands and feet. Numbness, tingling, burning pain. It can persist long after treatment ends.

On top of the disease itself, the treatments are intense. Most people go through multiple rounds of chemotherapy, targeted therapy with drugs like lenalidomide, daratumumab, and dexamethasone, and many end up needing a stem cell transplant. Each of these carries its own set of side effects that limit what you can do.

The Blue Book Listing: Section 13.07 Multiple Myeloma

SSA evaluates multiple myeloma under Blue Book Section 13.07. This listing has specific criteria that, if met, result in automatic approval at the medical listing level. You do not need to prove you cannot work if you meet the listing. SSA just accepts that you are disabled.

Here is what 13.07 requires:

Path 1: Failure to Respond or Disease Progression Despite Treatment

If your multiple myeloma did not respond to initial treatment, or if it came back or got worse despite treatment, you meet the listing. This is the most common qualification path for myeloma patients.

"Failure to respond" means the cancer kept growing or did not significantly decrease after your first line of therapy. "Progression despite treatment" means you initially responded but the cancer came back while you were still being treated or shortly after.

Path 2: Bone Marrow or Stem Cell Transplant

If you had an autologous or allogeneic stem cell transplant for your myeloma, SSA considers you disabled for at least 12 months from the date of the transplant. This is an automatic approval. You do not need to prove anything beyond the transplant itself.

After 12 months, SSA will reevaluate your condition. If you are still unable to work because of ongoing transplant complications, graft-versus-host disease, continued treatment, or the myeloma came back, your benefits continue.

What If You Do Not Meet the Listing Exactly?

Here is where a lot of myeloma patients get confused. Your cancer might be responding to treatment. Maybe it is in partial remission. That means you do not technically meet 13.07 because the cancer has not "failed to respond" or "progressed despite treatment."

But you still cannot work. The treatment side effects alone are keeping you home.

This is where the RFC (Residual Functional Capacity) assessment comes in. SSA looks at what you can still do despite your condition. If your RFC shows you cannot sustain full-time work, you get approved even without meeting the listing.

Common myeloma-related limitations that affect your RFC:

• Cannot sit for more than 2 hours without repositioning due to bone pain
• Cannot stand or walk for more than 4 hours in an 8-hour day
• Cannot lift more than 10 pounds due to fracture risk
• Need to lie down during the day due to extreme fatigue
• Miss more than 4 days of work per month due to treatment sessions and recovery
• Cannot maintain concentration due to "chemo brain" or pain medication effects
• Cannot be around people due to immunosuppression and infection risk

If you are over age 50, the Grid Rules work in your favor. SSA becomes more lenient about what "other work" you could do, especially if your previous jobs involved physical labor.

Medical Evidence SSA Needs for a Myeloma Claim

Your medical records are the backbone of your disability claim. Without proper documentation, even the most serious case of myeloma can get denied. Here is exactly what you need:

Diagnostic Evidence

• Bone marrow biopsy results showing the percentage of abnormal plasma cells
• Serum protein electrophoresis (SPEP) and immunofixation results identifying the type of monoclonal protein
• Free light chain assay results
• Beta-2 microglobulin and albumin levels for staging
• Imaging - PET/CT scans, MRI, or skeletal surveys showing bone lesions
• Cytogenetics and FISH testing results for risk stratification

Treatment Records

• All chemotherapy and targeted therapy regimen records
• Radiation treatment records if applicable
• Stem cell or bone marrow transplant records if applicable
• Documentation of each treatment cycle and how you responded
• Records showing disease progression or relapse after treatment

Functional Limitation Evidence

• A medical source statement from your treating oncologist or hematologist describing specific functional limitations
• Documentation of side effects from each medication
• Records of hospitalizations, ER visits, and missed appointments due to illness
• Lab work showing ongoing anemia, kidney function, and immune markers

Staging and How It Affects Your Claim

Multiple myeloma is staged using the Revised International Staging System (R-ISS), which has four stages based on blood markers and genetic risk factors.

Higher stages generally mean stronger claims because the disease is more aggressive and treatment is more intensive. But even Stage I myeloma can qualify if treatment side effects are severe enough or if the disease comes back after initial response.

Multiple Myeloma and the Compassionate Allowances Program

Here is something that frustrates a lot of myeloma patients and their doctors. Multiple myeloma is not on SSA's Compassionate Allowances list as of 2026. This is the fast-track program that processes claims in days or weeks instead of months.

Other blood cancers like acute leukemia and relapsed non-Hodgkin lymphoma are on the list. There is an active push from the International Myeloma Foundation and oncology groups to get myeloma added, and a recent paper in the medical literature called specifically for this change. But for now, your claim goes through the standard process.

That said, some myeloma cases do get processed faster than average if the evidence clearly shows you meet Listing 13.07. A well-documented claim with clear evidence of treatment failure can be approved at the initial level in 3-4 months.

Treatment Types and Their Impact on Your Claim

The type of treatment you are receiving matters for your disability claim because different treatments cause different side effects and have different implications for how long you will be unable to work.

First-Line Chemotherapy and Targeted Therapy

Most myeloma patients start with a combination regimen. The current standard first-line treatment in 2026 is DKRd (daratumumab, lenalidomide, bortezomib, and dexamethasone). This combination showed 59% of patients achieved minimal residual disease negativity in the ADVANCE clinical trial.

Common side effects that affect work ability:

• Bortezomib causes peripheral neuropathy in up to 40% of patients. Numbness and pain in hands and feet can last months or years after stopping the drug.
• Lenalidomide causes fatigue, low blood counts, and increased infection risk.
• Dexamethasone causes mood swings, insomnia, muscle weakness, high blood sugar, and bone loss.
• Daratumumab causes infusion reactions, respiratory infections, and fatigue.

Stem Cell Transplant

Autologous stem cell transplant is standard for eligible myeloma patients, usually those under 70 in good enough shape to tolerate the procedure. The transplant itself involves high-dose chemo to wipe out the bone marrow, then reinfusing your own stem cells.

Recovery takes 3-6 months minimum. Many patients deal with prolonged fatigue, infections, and organ effects for a year or longer. As mentioned above, SSA grants automatic disability for 12 months from the transplant date.

CAR T-Cell Therapy and Bispecific Antibodies

These newer treatments are being used more in 2026, especially for relapsed myeloma. CAR T-cell therapy involves modifying your own immune cells to attack myeloma cells. Bispecific antibodies direct your immune system to target myeloma.

Both carry serious side effects including cytokine release syndrome, neurotoxicity, and severe immune suppression. If you are on one of these therapies, document every side effect and hospitalization. They strongly support a disability claim.

SSDI vs. SSI: Which Benefits Apply?

There are two disability programs that cover multiple myeloma patients:

SSDI (Social Security Disability Insurance) is for people who have worked and paid Social Security taxes. You need enough work credits, which depends on your age. Most people over 31 need 20 credits earned in the last 10 years. The average SSDI payment in 2026 is $1,630 per month, with a maximum of $4,152.

SSI (Supplemental Security Income) is for people with limited income and assets, regardless of work history. The federal SSI payment in 2026 is $994 per month for an individual. Your total countable assets cannot exceed $2,000.

Some people qualify for both programs at the same time if their SSDI payment is low enough. This is called concurrent benefits.

For more details on the differences, check out our SSDI vs. SSI comparison guide.

What to Do If Your Myeloma Claim Gets Denied

About 62% of all initial disability claims get denied, but the numbers are better for cancer claims. Still, denials happen, especially when medical records are incomplete or the DDS examiner does not fully understand the condition.

If you get denied:

1. Request reconsideration within 60 days. A different DDS examiner reviews your case fresh. Use this time to get any missing medical records submitted.
2. Request a hearing before an ALJ. If reconsideration fails, this is where most myeloma claims eventually get approved. You sit in front of a judge who reviews your case individually. The hearing level has much higher approval rates than the initial level.
3. Get a disability attorney or representative. They work on contingency, meaning they only get paid if you win. The fee is capped at 25% of your back pay or $7,500, whichever is less. For a cancer claim, having someone who knows how to present the evidence makes a big difference.

For a deeper look at the full appeal process, read our guide on the Appeals Council review process.

How Long Does It Take to Get Approved?

Here is a realistic timeline for a multiple myeloma disability claim in 2026:

The best way to speed things up is to submit a complete claim from day one. That means all the diagnostic evidence, treatment records, and functional limitation documentation discussed above. If SSA has everything they need, they do not have to spend months requesting records.

Back Pay and When You Can Expect Payment

If your claim is approved, you are likely owed back pay. SSDI back pay goes back to your established onset date (the date SSA determines your disability began) minus a mandatory five-month waiting period. You can receive up to 12 months of retroactive benefits before your application date.

For example, if your myeloma diagnosis was in January 2025 and you are approved in June 2026, your onset date might be set to January 2025. After the five-month waiting period, your back pay would cover June 2025 through May 2026, roughly 12 months at whatever your monthly SSDI amount is.

At the average payment of $1,630 per month, that comes to about $19,560 in back pay. This is usually paid as a lump sum within 60 days of your approval.

For more details on how this calculation works, check out our SSDI back pay calculator.

Tips for Strengthening Your Multiple Myeloma Claim

1. File as soon as you cannot work. Your application date affects your back pay. Do not wait for your treatment to be "finished." Myeloma treatment can go on for years.
2. Keep every single medical record. Every lab result, every imaging scan, every treatment record. If your oncologist mentions fatigue or pain in their notes, that matters.
3. Ask your oncologist for a medical source statement. This is a detailed letter describing your functional limitations. It should be specific: "Patient cannot stand for more than 30 minutes" is much more useful than "patient is unable to work."
4. Document your bad days. Keep a journal of days when symptoms prevent you from doing normal activities. Note the date, what happened, and what you could not do. This supports your claim at a hearing.
5. Report all your conditions, not just the myeloma. If you also have kidney disease, neuropathy, depression, or any other condition related to or separate from your myeloma, list them all on your application. SSA evaluates the combined effect.
6. Do not downplay your symptoms. When SSA asks you about daily activities on forms like the SSA-3368, describe your worst days, not your best. If you can cook dinner once a week but not most days, say that.